Category: Treatments

Superior Mesenteric Artery Thrombosis Following Severe COVID-19 Pneumonia

Posted on | Posted on John Murphy | Leave a Comment on Superior Mesenteric Artery Thrombosis Following Severe COVID-19 Pneumonia

Authors: Abdulhadi A Alali,1Mohammed O Baqais,2Fayez M Albishi,3, et. al. Cureus. (11):19954. doi: 10.7759/cureus.19954PMCID: PMC8713302PMID: 34976537 Abstract Thrombotic events are well-recognized complications of coronavirus disease 2019 (COVID-19). The incidence of such complications is highly related to the severity of COVID-19 pneumonia. Recent evidence suggests that the coagulopathy of COVID-19 may persist for some period even after the full recovery from […]

The Invisible Damage: How COVID Rewires Our Brains

Posted on | Posted on John Murphy | Leave a Comment on The Invisible Damage: How COVID Rewires Our Brains

By University of Colorado at Boulder, University of Colorado Boulder scientists have discovered that proteins left by COVID-19 can significantly lower cortisol levels in the brain, leading to heightened immune responses to new stressors. This research, focusing on the neurological symptoms of Long COVID, utilized rats to demonstrate how SARS-CoV-2 antigens persist in the body and alter brain function. This […]

Pfizer Infringed On Moderna Patent With COVID-19 Vaccine: Court

Posted on | Posted on John Murphy | Leave a Comment on Pfizer Infringed On Moderna Patent With COVID-19 Vaccine: Court

JUL 05, 2024 – 07:00 PM, Authored by Zachary Stieber via The Epoch Times, Pfizer and BioNTech’s COVID-19 vaccine infringed on a patent held by rival Moderna, the High Court in London, England, found in a decision released on July 2. The Pfizer-BioNTech and Moderna COVID-19 vaccines both utilize messenger ribonucleic acid (mRNA) technology. Moderna […]

COVID-19 and spinal cord injury: clinical presentation, clinical course, and clinical outcomes of people hospitalised

Posted on | Posted on John Murphy | Leave a Comment on COVID-19 and spinal cord injury: clinical presentation, clinical course, and clinical outcomes of people hospitalised

Inge E. Eriks-Hoogland, Michael A. Barth, Lorena L. Müller, et. al. Spinal Cord Series and Cases volume 10, Article number: 5 (2024)  Abstract Study design Retrospective study Objectives To describe the presenting symptoms/signs, clinical course and outcomes in hospitalised people with spinal cord injury (SCI) and symptomatic COVID-19 infections. Setting One university hospital and two SCI centres in Switzerland. Methods Descriptive analysis of […]

Study of 1.7 Million Kids and Teens Who Got Pfizer COVID Vaccine Found Myopericarditis Only in Vaxed Groups

Posted on | Posted on John Murphy | Leave a Comment on Study of 1.7 Million Kids and Teens Who Got Pfizer COVID Vaccine Found Myopericarditis Only in Vaxed Groups

by Brenda Baletti, Ph.D. The Pfizer-BioNTech COVID-19 vaccine provided children and teens in England with only about 14 to 15 weeks of protection against testing positive for the virus, according to a preprint study of over 1.7 million children ages 5 to 15 in the English National Healthcare System (NHS). Researchers investigating the safety and effectiveness of Pfizer’s vaccine in […]

Nondisclosure: Vaccine Ad Blitz Sidestepped Transparency Rules

Posted on | Posted on John Murphy | Leave a Comment on Nondisclosure: Vaccine Ad Blitz Sidestepped Transparency Rules

By Lee Fang, RealClearInvestigations “A bun in the toaster oven,” a woman exclaims off-camera, handing an ultrasound image to family members who erupt into tearful emotion over the news. “Oh my God!”  The touching baby announcement video then gets down to business as text appears on the screen amidst the ongoing celebration, suggesting the best way to stay alive […]

Long COVID patients report improvements following self-regulation therapy, study finds

Posted on | Posted on John Murphy | Leave a Comment on Long COVID patients report improvements following self-regulation therapy, study finds

by University of California, Los Angeles A new UCLA-led study suggests that some people living with long COVID may be able to alleviate certain symptoms by using short-term, self-regulating therapies. The small-scale study, published in the Journal of Psychosomatic Research, recruited a group of 20 long COVID patients, many of whom had been experiencing symptoms for more than […]

Thousands Believe Covid Vaccines Harmed Them. Is Anyone Listening?

Posted on | Posted on John Murphy | Leave a Comment on Thousands Believe Covid Vaccines Harmed Them. Is Anyone Listening?

May 3, 2024 Within minutes of getting the Johnson & Johnson Covid-19 vaccine, Michelle Zimmerman felt pain racing from her left arm up to her ear and down to her fingertips. Within days, she was unbearably sensitive to light and struggled to remember simple facts. She was 37, with a Ph.D. in neuroscience, and until […]

Safety and efficacy of low dose naltrexone in a long covid cohort; an interventional pre-post study.

Posted on | Posted on John Murphy | Leave a Comment on Safety and efficacy of low dose naltrexone in a long covid cohort; an interventional pre-post study.

O’Kelly B 1,2, Vidal L 2, McHugh T 2, et. al. Brain, Behavior, & Immunity – Health, 03 Jul 2022, 24:100485, https://doi.org/10.1016/j.bbih.2022.100485 PMID: 35814187 PMCID: PMC9250701 Abstract  Background Up to 37.7% of patients experience symptoms beyond 12 weeks after infection with SARS-CoV-2. To date care for people with long covid has centred around multidisciplinary rehabilitation, self care and self pacing. No pharmacotherapy has been […]

Asymptomatic COVID-19 Infection-Induced Rhabdomyolysis in the Backdrop of Statin-Cyclosporine Drug Interaction

Posted on | Posted on John Murphy | Leave a Comment on Asymptomatic COVID-19 Infection-Induced Rhabdomyolysis in the Backdrop of Statin-Cyclosporine Drug Interaction

Vivek Nayak M • FNU Bipasha • Kotresha Neelakantappa, DOI: 10.7759/cureus.68127  Abstract Rhabdomyolysis involves skeletal muscle breakdown leading to high serum creatine kinase (CK) levels and myoglobinuria. Here, we report the case of a middle-aged man who developed rhabdomyolysis, resulting in acute kidney injury (AKI) over pre-existing chronic kidney disease (stage 3a) secondary to focal segmental glomerulosclerosis (primary FSGS), during […]